Alltrna: Creating the tRNA modality

Flagship-launched Alltrna is building on recent mRNA momentum with a platform designed to uncover the therapeutic potential of another type of RNA — tRNA — and turn it into an entirely new therapeutic modality.

The company was launched under Flagship Pioneering’s incubation model with $50 million in committed capital from the VC and a plan to develop therapeutics that alter protein expression at the final step of the synthesis process. ...